Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
65.38
-2.17 (-3.21%)
Oct 15, 2026, 2:38 PM EDT - Market open
Vaxcyte Employees
Vaxcyte had 507 employees as of December 31, 2025. The number of employees increased by 93 or 22.46% compared to the previous year. That makes Vaxcyte the 19,932nd largest employer in the world and 2,680th in the United States.
Employees
507
Change (1Y)
93
Growth (1Y)
22.46%
Revenue / Employee
n/a
Profits / Employee
-$2,099,134
Market Cap
10.29B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 507 | 93 | 22.46% |
| Dec 31, 2024 | 414 | 160 | 62.99% |
| Dec 31, 2023 | 254 | 96 | 60.76% |
| Dec 31, 2022 | 158 | 69 | 77.53% |
| Dec 31, 2021 | 89 | 31 | 53.45% |
| Dec 31, 2020 | 58 | 15 | 34.88% |
| Dec 31, 2019 | 43 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,000 |
| BridgeBio Pharma | 1,003 |
| Twist Bioscience | 979 |
| Madrigal Pharmaceuticals | 915 |
| Corcept Therapeutics | 730 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
PCVX News
- 8 days ago - Vaxcyte 7.412M share Spot Secondary priced at $64.00 - TheFly
- 8 days ago - Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes - GlobeNewsWire
- 9 days ago - Vaxcyte falls -11.3% - TheFly
- 9 days ago - Vaxcyte price target raised to $146 from $130 at BofA - TheFly
- 9 days ago - Vaxcyte files to sell $500M of common stock, $500M of convertible senior notes - TheFly
- 9 days ago - Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes - GlobeNewsWire
- 10 days ago - Vaxcyte price target raised to $122 from $110 at Needham - TheFly
- 10 days ago - Vaxcyte rises 33.7% - TheFly